Comment on Impact of Renin‐Angiotensin‐Aldosterone System Inhibitors on Liver‐Related Events and Mortality in Patients With Cirrhosis: A Meta‐Analysis of Real‐World Evidence
We read with interest the recent meta-analysis by Chen et al. exploring the impact of renin-angiotensin-aldosterone system inhibitors (RAASi) on liver-related events (LREs) and mortality in cirrhosis [1].Here, we would like to offer several issues.
Authors
- Jian Liu (ORCID: https://orcid.org/0000-0003-1920-2641)
- Linhai Xu
Institutions
- Shuozhou Central Hospital (CN)
Publication Details
- Journal
- Journal of Gastroenterology and Hepatology
- Published
- 2025-10-16
- DOI
- https://doi.org/10.1111/jgh.70114
- Primary Topic
- Liver Disease and Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00